Its sold as a research chemical or supplement in most countries, intended for research purposes only. This regulatory gray area means: Quality control varies significantly between suppliers Purity and actual peptide content may not match labels No official medical oversight or standardized protocols exist It cannot legally be marketed for treating or preventing any medical condition This regulatory status reflects the current state of peptide research generallymany promising compounds exist in this space between laboratory research and approved therapeutic use
Lab tested to show increased Glutathione levels
Mistakes happen when researchers apply reconstituted storage rules to lyophilized powder (unnecessarily restrictive) or, worse, apply lyophilized storage assumptions to reconstituted solution (dangerously lax)
Formulation: Powder
Akaydn SY, Saliholu EM, Gngr DG, Karanlk H, Demokan S
[14] Safety interpretation depends on species, exposure route, exposure duration, formulation, impurity profile, study design, and regulatory context